Cascadian Therapeutics Inc (CASC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2012 | 12-2011 | 12-2010 | 12-2009 | 12-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,415 | -42,656 | -15,618 | -17,219 | 7,422 |
| Depreciation Amortization | 1,433 | 628 | 462 | 269 | 422 |
| Accounts receivable | 11 | -203 | -58 | 1,782 | 194 |
| Accounts payable and accrued liabilities | 674 | -165 | -2 | 147 | 166 |
| Other Working Capital | -258 | 1,406 | -980 | 430 | -21,251 |
| Other Operating Activity | -24,948 | 19,821 | -1,509 | 5,479 | 8,161 |
| Operating Cash Flow | $-26,503 | $-21,169 | $-17,705 | $-9,112 | $-4,886 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -7,519 | -31,435 | -9,119 | -14,244 | 11,870 |
| PPE Investments | -752 | -142 | -324 | -1,433 | -196 |
| Other Investing Activity | 0 | 0 | 0 | 34 | 151 |
| Investing Cash Flow | $-8,271 | $-31,577 | $-9,443 | $-15,643 | $11,825 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -5,044 | -151 | N/A | N/A | N/A |
| Common Stock Issued | 50,475 | 54,188 | 13,688 | 24,563 | N/A |
| Other Financing Activity | 0 | 4,804 | 0 | 0 | -93 |
| Financing Cash Flow | $45,431 | $58,841 | $13,688 | $24,563 | $-93 |
| Exchange Rate Effect | N/A | N/A | N/A | N/A | 285 |
| Beginning Cash Position | 11,609 | 5,514 | 18,974 | 19,166 | 12,035 |
| End Cash Position | 22,266 | 11,609 | 5,514 | 18,974 | 19,166 |
| Net Cash Flow | $10,657 | $6,095 | $-13,460 | $-192 | $7,131 |
| Free Cash Flow | |||||
| Operating Cash Flow | -26,503 | -21,169 | -17,705 | -9,112 | -4,886 |
| Capital Expenditure | -752 | -142 | -324 | -1,433 | -744 |
| Free Cash Flow | -27,255 | -21,311 | -18,029 | -10,545 | -5,630 |